STU-2026-089 — Phase III Oncology — Compound SYN-441
Certificates are hashed on receipt and passed through the same OCR pipeline as paper binders. The matrix below does not move until a reviewer verifies the extraction — an unverified certificate cannot lift the Gatekeeper block.
Under the Gatekeeper rule, an expired or incomplete required module invalidates any delegation that depends on it.
| Staff Member | Role | GCP-2026-V2 | PROTO-089-V3 | IATA-2025 | EDC-RAVE-V5 |
|---|---|---|---|---|---|
|
Dr. Alice Nakamura [email protected] |
Principal Investigator |
Completed Due 22 Jun 2027 |
Completed Due 22 Feb 2027 |
Completed Due 23 Apr 2027 |
Completed Due 24 Nov 2026 |
|
Dr. Ben Osei [email protected] |
Sub-Investigator |
Completed Due 24 Dec 2026 |
Completed Due 23 Jan 2027 |
Assigned Due 16 Sep 2026 |
Completed Due 25 Oct 2026 |
|
Clara Mendes [email protected] |
Clinical Research Coordinator |
Completed Due 14 Mar 2027 |
In Progress Due 09 Sep 2026 |
Completed Due 02 Jul 2027 |
Completed Due 10 Oct 2026 |
|
Daniel Whitfield [email protected] |
Clinical Research Coordinator |
Completed Due 29 Nov 2026 |
In Progress Due 02 Sep 2026 |
Assigned Due 23 Sep 2026 |
In Progress Due 05 Sep 2026 |
|
Dr. Eva Lindqvist [email protected] |
Sub-Investigator |
Expired Due 14 Aug 2026 |
Assigned Due 25 Sep 2026 |
Assigned Due 25 Sep 2026 |
Assigned Due 25 Sep 2026 |
|
Hannah Pike [email protected] |
Clinical Research Coordinator |
In Progress Due 04 Sep 2026 |
Assigned Due 20 Sep 2026 |
Expired Due 23 Aug 2026 |
Assigned Due 05 Oct 2026 |